Prevalence, duration of illness, and mortality of lumpy skin disease at Chuadanga Sadar Upazila, Bangladesh
Abstract
Background: Lumpy skin disease (LSD) has emerged as a significant threat to cattle production in Chuadanga Sadar Upazila, Bangladesh.
Materials and Methods: Our study aimed to assess the prevalence, mortality, and demographic distribution of LSD in the study area based on pre-structured questionnaire for face-to-face interview in Chuadanga Sadar Upazila, Bangladesh, from August 7, 2022, to October 6, 2022.
Results: The incidence risk of LSD was 22.24% with variations observed between indigenous (51.77%) and cross-bred cattle (48.23%). The overall LSD mortality was 7%. Cross-breed male cattle showed a higher risk of LSD (57.35%) in comparison to cross-breed female-cattle (42.65%). The LSD prevalence was relatively higher in age-group > 6 months than other age groups. The average duration of illness varied among indigenous and cross-bred cattle. Indigenous cattle showed a longer average illness duration (6.79 days) compared to cross-breed cattle (5.5 days). The highest risks were observed in cattle aged up to 30 days (4.4%), with indigenous cattle accounting for 43% and cross-bred cattle for 57%.
Conclusion: The findings of this study provide valuable insights into the incidence risk, mortality, and demographic distribution of LSD in cattle at Chuadanga Sadar Upazila. The results offer a foundation for developing targeted interventions to control and manage LSD, thereby safeguarding cattle production in the region. Specifically, to optimize LSD vaccination strategies, it is recommended to prioritize indigenous cattle and male cross-bred due to their elevated susceptibility. Furthermore, particular emphasis should be placed on cattle aged below one month, with a specific focus on prioritizing treatment for male cross-bred to effectively mitigate the risk of fatalities.
Downloads
Copyright (c) 2023 Bangladesh Journal of Veterinary Medicine (BJVM)
This work is licensed under a Creative Commons Attribution 4.0 International License.